Press releases

Welcome to the press section. If you want to be included in our media database, please send us an email.

Filter Press releases:


11 January 2022

BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology

Read press release

8 December 2021

Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01)

Read press release

3 November 2021

BRAIN and SAMS apply BEC gene-editing technology to Omega-3 Compounds from Marine Organisms

Read press release

15 September 2021

BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives

Read press release

15 September 2021

BRAIN Biotech AG resolves on a cash capital increase from authorised capital

Read press release

Screenshots from BRAIN Biotech´s CMD presentations
3 September 2021

Capital Markets Day BRAIN Biotech AG: Focus on BEC Technology and its Transformational Potential

Read press release

1 September 2021

BRAIN appoints University of Leiden as partner for BEC-enabled production strain development

Read press release

30 August 2021

BRAIN Biotech AG 9M ‘20/’21 Results

Read press release

28 July 2021

Sartorius and BRAIN jointly researching and adapting novel CRISPR Cas-nucleases

Read press release

BRAIN Biotech Laboratory: Culture plate with cell colonies where successful genome editing is indicated by red coloration.
21 July 2021

Novel Genome Editing Tool: Filing of International Patent Application

Read press release

Share this page